News coverage about Aemetis (NASDAQ:AMTX) has trended somewhat positive recently, Accern reports. Accern identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Aemetis earned a media sentiment score of 0.06 on Accern’s scale. Accern also gave news articles about the specialty chemicals company an impact score of 46.4733687481548 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Several equities research analysts have recently weighed in on AMTX shares. FBR & Co reaffirmed a “neutral” rating and issued a $2.00 price target on shares of Aemetis in a research report on Saturday, August 19th. Zacks Investment Research raised shares of Aemetis from a “sell” rating to a “hold” rating in a research report on Tuesday, October 17th. Finally, B. Riley reaffirmed a “hold” rating and issued a $2.00 price target on shares of Aemetis in a research report on Monday, November 13th.

Shares of Aemetis (NASDAQ AMTX) opened at $0.70 on Tuesday. Aemetis has a 52-week low of $0.53 and a 52-week high of $2.50. The company has a debt-to-equity ratio of -1.87, a quick ratio of 0.20 and a current ratio of 0.37.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was stolen and reposted in violation of United States & international copyright and trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-aemetis-amtx-stock-price/1717025.html.

About Aemetis

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Insider Buying and Selling by Quarter for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.